You are here: All Products  > Merck's Keytruda Approved as Monotherapy for Lung Cancer in China

Merck's Keytruda Approved as Monotherapy for Lung Cancer in China

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products